Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 4/2017

26.06.2017 | Highlights

News and views

verfasst von: Sander M. Houten

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Excerpt

Lysine acetylation is an important posttranslational modification of proteins and plays a role in many biological pathways, such as epigenetic regulation of gene expression. In addition, lysine in protein can be acylated with a variety of other molecules, including propionyl, butyryl, and malonyl groups. While sirtuins are now known to be nicotinamide adenine dinucleotide (NAD)+-dependent protein deacylases that catalyze the removal of these modifications, the identification of specific acyltransferases that perform the acylation reaction has been challenging. Indeed, there is evidence that acyl-CoAs are reactive molecules that can chemically (nonenzymatically) modify proteins. In inborn errors of acyl-CoA metabolism, aberrant protein acylation is a frequent observation, but it is currently unknown whether it plays a role in pathophysiology (Pougovkina et al. 2014; Tan et al. 2014). Wagner et al. now show that short-chain dicarboxylate-CoAs, such as succinyl-, glutaryl- and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), are inherently unstable and form a highly reactive anhydride after ring closure (Wagner et al. 2017). As a consequence, the proteome of liver mitochondria isolated from HMG-CoA lyase knockout (KO) mice is heavily HMGylated and that of glutaryl-CoA dehydrogenase KO mice is heavily glutarylated. Wagner et al. further demonstrate that many protein sites are uniquely modified by either HMG-CoA or glutaryl-CoA, but some pathways, such as the tricarboxylic acid cycle, are commonly modified (Wagner et al. 2017). Given that these modifications affect the activity of many enzymes, protein acylation has been proposed as a biological regulatory mechanism that controls metabolism. Alternatively, many acylation events may be collateral damage of metabolic processes, requiring a repair mechanism that is in turn provided by the sirtuins. Regardless, this new work further establishes evidence that aberrant protein acylation may be a recurring theme in the pathophysiology of inborn errors of metabolism. …
Literatur
Zurück zum Zitat Pougovkina O, te Brinke H, Wanders RJ, Houten SM, de Boer VC (2014) Aberrant protein acylation is a common observation in inborn errors of acyl-CoA metabolism. J Inherit Metab Dis 37:709–714CrossRefPubMed Pougovkina O, te Brinke H, Wanders RJ, Houten SM, de Boer VC (2014) Aberrant protein acylation is a common observation in inborn errors of acyl-CoA metabolism. J Inherit Metab Dis 37:709–714CrossRefPubMed
Zurück zum Zitat Tan M, Peng C, Anderson KA et al (2014) Lysine glutarylation is a protein posttranslational modification regulated by SIRT5. Cell Metab 19:605–617CrossRefPubMedPubMedCentral Tan M, Peng C, Anderson KA et al (2014) Lysine glutarylation is a protein posttranslational modification regulated by SIRT5. Cell Metab 19:605–617CrossRefPubMedPubMedCentral
Zurück zum Zitat Wagner GR, Bhatt DP, O’Connell TM et al (2017) A class of reactive acyl-CoA species reveals the non-enzymatic origins of protein acylation. Cell Metab 25(823–837):e828 Wagner GR, Bhatt DP, O’Connell TM et al (2017) A class of reactive acyl-CoA species reveals the non-enzymatic origins of protein acylation. Cell Metab 25(823–837):e828
Metadaten
Titel
News and views
verfasst von
Sander M. Houten
Publikationsdatum
26.06.2017
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 4/2017
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0062-2

Weitere Artikel der Ausgabe 4/2017

Journal of Inherited Metabolic Disease 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.